Drugmaker Aquestive's Brass Sued Over FDA Setback
Executives and directors of pharmaceutical company Aquestive Therapeutics Inc. were hit with a shareholder's derivative suit Wednesday accusing them of ignoring deficiencies in a research study for Aquestive's allergic reaction treatment,...To view the full article, register now.
Already a subscriber? Click here to view full article